<html><head><link rel="stylesheet" type="text/css" href="usc.css"/><title>U.S.C. Title 21 - FOOD AND DRUGS</title></head><body>
<span style="font-weight:bold;font-size:12pt;">21 U.S.C. </span><br/>
<span style="font-size:10pt">United States Code, 1997 Edition</span><br/>
<span style="font-size:10pt">Title 21 - FOOD AND DRUGS</span><br/>
<span style="font-size:10pt">CHAPTER 13 - DRUG ABUSE PREVENTION AND CONTROL</span><br/>
<span style="font-size:10pt">SUBCHAPTER I - CONTROL AND ENFORCEMENT</span><br/>
<span style="font-size:10pt">Part C - Registration of Manufacturers, Distributors, and Dispensers of Controlled Substances</span><br/>
<span style="font-size:10pt">Sec. 823 - Registration requirements</span><br/>
<span style="font-size:10pt">From the U.S. Government Printing Office, <a href="http://www.gpo.gov">www.gpo.gov</a></span><br/><br/>
<!-- documentid:21_823  usckey:210000000082300000000000000000000 currentthrough:19980126 documentPDFPage:339 -->
<!-- itempath:/210/CHAPTER 13/SUBCHAPTER I/Part C/Sec. 823 -->
<!-- itemsortkey:210AAPN -->
<!-- expcite:TITLE 21-FOOD AND DRUGS!@!CHAPTER 13-DRUG ABUSE PREVENTION AND CONTROL!@!SUBCHAPTER I-CONTROL AND ENFORCEMENT!@!Part C-Registration of Manufacturers, Distributors, and Dispensers of Controlled Substances!@!Sec. 823 -->
<!-- field-start:head -->
<h3 class="section-head">&sect;823. Registration requirements</h3>
<!-- field-end:head -->
<!-- field-start:statute -->
<h4 class="subsection-head">(a) Manufacturers of controlled substances in schedule I or II</h4>
<p class="statutory-body">The Attorney General shall register an applicant to manufacture controlled substances in schedule I or II if he determines that such registration is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. In determining the public interest, the following factors shall be considered:</p>
<p class="statutory-body-1em">(1) maintenance of effective controls against diversion of particular controlled substances and any controlled substance in schedule I or II compounded therefrom into other than legitimate medical, scientific, research, or industrial channels, by limiting the importation and bulk manufacture of such controlled substances to a number of establishments which can produce an adequate and uninterrupted supply of these substances under adequately competitive conditions for legitimate medical, scientific, research, and industrial purposes;</p>
<p class="statutory-body-1em">(2) compliance with applicable State and local law;</p>
<p class="statutory-body-1em">(3) promotion of technical advances in the art of manufacturing these substances and the development of new substances;</p>
<p class="statutory-body-1em">(4) prior conviction record of applicant under Federal and State laws relating to the manufacture, distribution, or dispensing of such substances;</p>
<p class="statutory-body-1em">(5) past experience in the manufacture of controlled substances, and the existence in the establishment of effective control against diversion; and</p>
<p class="statutory-body-1em">(6) such other factors as may be relevant to and consistent with the public health and safety.</p>
<h4 class="subsection-head">(b) Distributors of controlled substances in schedule I or II</h4>
<p class="statutory-body">The Attorney General shall register an applicant to distribute a controlled substance in schedule I or II unless he determines that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the following factors shall be considered:</p>
<p class="statutory-body-1em">(1) maintenance of effective control against diversion of particular controlled substances into other than legitimate medical, scientific, and industrial channels;</p>
<p class="statutory-body-1em">(2) compliance with applicable State and local law;</p>
<!-- PDFPage:340 --><p class="statutory-body-1em">(3) prior conviction record of applicant under Federal or State laws relating to the manufacture, distribution, or dispensing of such substances;</p>
<p class="statutory-body-1em">(4) past experience in the distribution of controlled substances; and</p>
<p class="statutory-body-1em">(5) such other factors as may be relevant to and consistent with the public health and safety.</p>
<h4 class="subsection-head">(c) Limits of authorized activities</h4>
<p class="statutory-body">Registration granted under subsections (a) and (b) of this section shall not entitle a registrant to (1) manufacture or distribute controlled substances in schedule I or II other than those specified in the registration, or (2) manufacture any quantity of those controlled substances in excess of the quota assigned pursuant to section 826 of this title.</p>
<h4 class="subsection-head">(d) Manufacturers of controlled substances in schedule III, IV, or V</h4>
<p class="statutory-body">The Attorney General shall register an applicant to manufacture controlled substances in schedule III, IV, or V, unless he determines that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the following factors shall be considered:</p>
<p class="statutory-body-1em">(1) maintenance of effective controls against diversion of particular controlled substances and any controlled substance in schedule III, IV, or V compounded therefrom into other than legitimate medical, scientific, or industrial channels;</p>
<p class="statutory-body-1em">(2) compliance with applicable State and local law;</p>
<p class="statutory-body-1em">(3) promotion of technical advances in the art of manufacturing these substances and the development of new substances;</p>
<p class="statutory-body-1em">(4) prior conviction record of applicant under Federal or State laws relating to the manufacture, distribution, or dispensing of such substances;</p>
<p class="statutory-body-1em">(5) past experience in the manufacture, distribution, and dispensing of controlled substances, and the existence in the establishment of effective controls against diversion; and</p>
<p class="statutory-body-1em">(6) such other factors as may be relevant to and consistent with the public health and safety.</p>
<h4 class="subsection-head">(e) Distributors of controlled substances in schedule III, IV, or V</h4>
<p class="statutory-body">The Attorney General shall register an applicant to distribute controlled substances in schedule III, IV, or V, unless he determines that the issuance of such registration is inconsistent with the public interest. In determining the public interest, the following factors shall be considered:</p>
<p class="statutory-body-1em">(1) maintenance of effective controls against diversion of particular controlled substances into other than legitimate medical, scientific, and industrial channels;</p>
<p class="statutory-body-1em">(2) compliance with applicable State and local law;</p>
<p class="statutory-body-1em">(3) prior conviction record of applicant under Federal or State laws relating to the manufacture, distribution, or dispensing of such substances;</p>
<p class="statutory-body-1em">(4) past experience in the distribution of controlled substances; and</p>
<p class="statutory-body-1em">(5) such other factors as may be relevant to and consistent with the public health and safety.</p>
<h4 class="subsection-head">(f) Research by practitioners; pharmacies; research applications; construction of Article 7 of the Convention on Psychotropic Substances</h4>
<p class="statutory-body">The Attorney General shall register practitioners (including pharmacies, as distinguished from pharmacists) to dispense, or conduct research with, controlled substances in schedule II, III, IV, or V, if the applicant is authorized to dispense, or conduct research with respect to, controlled substances under the laws of the State in which he practices. The Attorney General may deny an application for such registration if he determines that the issuance of such registration would be inconsistent with the public interest. In determining the public interest, the following factors shall be considered:</p>
<p class="statutory-body-1em">(1) The recommendation of the appropriate State licensing board or professional disciplinary authority.</p>
<p class="statutory-body-1em">(2) The applicant's experience in dispensing, or conducting research with respect to controlled substances.</p>
<p class="statutory-body-1em">(3) The applicant's conviction record under Federal or State laws relating to the manufacture, distribution, or dispensing of controlled substances.</p>
<p class="statutory-body-1em">(4) Compliance with applicable State, Federal, or local laws relating to controlled substances.</p>
<p class="statutory-body-1em">(5) Such other conduct which may threaten the public health and safety.</p>
<br class="Q04" />
<p class="statutory-body-block">Separate registration under this part for practitioners engaging in research with controlled substances in schedule II, III, IV, or V, who are already registered under this part in another capacity, shall not be required. Registration applications by practitioners wishing to conduct research with controlled substances in schedule I shall be referred to the Secretary, who shall determine the qualifications and competency of each practitioner requesting registration, as well as the merits of the research protocol. The Secretary, in determining the merits of each research protocol, shall consult with the Attorney General as to effective procedures to adequately safeguard against diversion of such controlled substances from legitimate medical or scientific use. Registration for the purpose of bona fide research with controlled substances in schedule I by a practitioner deemed qualified by the Secretary may be denied by the Attorney General only on a ground specified in section 824(a) of this title. Article 7 of the Convention on Psychotropic Substances shall not be construed to prohibit, or impose additional restrictions upon, research involving drugs or other substances scheduled under the convention which is conducted in conformity with this subsection and other applicable provisions of this subchapter.</p>
<h4 class="subsection-head">(g) Practitioners dispensing narcotic drugs for narcotic treatment; annual registration; separate registration; qualifications</h4>
<p class="statutory-body">Practitioners who dispense narcotic drugs to individuals for maintenance treatment or de<!-- PDFPage:341 -->toxification treatment shall obtain annually a separate registration for that purpose. The Attorney General shall register an applicant to dispense narcotic drugs to individuals for maintenance treatment or detoxification treatment (or both)</p>
<p class="statutory-body-1em">(1) if the applicant is a practitioner who is determined by the Secretary to be qualified (under standards established by the Secretary) to engage in the treatment with respect to which registration is sought;</p>
<p class="statutory-body-1em">(2) if the Attorney General determines that the applicant will comply with standards established by the Attorney General respecting (A) security of stocks of narcotic drugs for such treatment, and (B) the maintenance of records (in accordance with section 827 of this title) on such drugs; and</p>
<p class="statutory-body-1em">(3) if the Secretary determines that the applicant will comply with standards established by the Secretary (after consultation with the Attorney General) respecting the quantities of narcotic drugs which may be provided for unsupervised use by individuals in such treatment.</p>
<h4 class="subsection-head">(h) Applicants for distribution of list I chemicals</h4>
<p class="statutory-body">The Attorney General shall register an applicant to distribute a list I chemical unless the Attorney General determines that registration of the applicant is inconsistent with the public interest. Registration under this subsection shall not be required for the distribution of a drug product that is exempted under section 802(39)(A)(iv) of this title. In determining the public interest for the purposes of this subsection, the Attorney General shall consider&mdash;</p>
<p class="statutory-body-1em">(1) maintenance by the applicant of effective controls against diversion of listed chemicals into other than legitimate channels;</p>
<p class="statutory-body-1em">(2) compliance by the applicant with applicable Federal, State, and local law;</p>
<p class="statutory-body-1em">(3) any prior conviction record of the applicant under Federal or State laws relating to controlled substances or to chemicals controlled under Federal or State law;</p>
<p class="statutory-body-1em">(4) any past experience of the applicant in the manufacture and distribution of chemicals; and</p>
<p class="statutory-body-1em">(5) such other factors as are relevant to and consistent with the public health and safety.</p>
<!-- field-end:statute -->
<!-- field-start:sourcecredit -->
<p class="source-credit">(Pub. L. 91&ndash;513, title II, &sect;303, Oct. 27, 1970, 84 Stat. 1253; Pub. L. 93&ndash;281, &sect;3, May 14, 1974, 88 Stat. 124; Pub. L. 95&ndash;633, title I, &sect;109, Nov. 10, 1978, 92 Stat. 3773; Pub. L. 98&ndash;473, title II, &sect;511, Oct. 12, 1984, 98 Stat. 2073; Pub. L. 103&ndash;200, &sect;3(c), Dec. 17, 1993, 107 Stat. 2336.)</p>
<!-- field-end:sourcecredit -->
<!-- field-start:notes -->
<!-- field-start:referenceintext-note -->
<h4 class="note-head">References in Text</h4>
<p class="note-body">Schedules I, II, III, IV, and V, referred to in subsecs. (a) to (f), are set out in section 812(c) of this title.</p>
<!-- field-end:referenceintext-note -->
<!-- field-start:amendment-note -->
<h4 class="note-head">Amendments</h4>
<p class="note-body">1993&mdash;Subsec. (h). Pub. L. 103&ndash;200 added subsec. (h).</p>
<p class="note-body">1984&mdash;Subsec. (f). Pub. L. 98&ndash;473 amended subsec. (f) generally, substituting provisions relating to registration authority of Attorney General respecting dispensation or conduct of research with controlled research, and separate authority of Secretary respecting registration, for provisions relating to general registration requirements respecting dispensation or conduct of research with controlled or nonnarcotic controlled substances.</p>
<p class="note-body">1978&mdash;Subsec. (f). Pub. L. 95&ndash;633 inserted provision relating to the construction of the Convention on Psychotropic Substances.</p>
<p class="note-body">1974&mdash;Subsec. (g). Pub. L. 93&ndash;281 added subsec. (g).</p>
<!-- field-end:amendment-note -->
<!-- field-start:effectivedate-amendment-note -->
<h4 class="note-head">Effective Date of 1993 Amendment</h4>
<p class="note-body">Amendment by Pub. L. 103&ndash;200 effective on date that is 120 days after Dec. 17, 1993, see section 11 of Pub. L. 103&ndash;200, set out as a note under section 802 of this title.</p>
<h4 class="note-head">Effective Date of 1978 Amendment</h4>
<p class="note-body">Amendment by Pub. L. 95&ndash;633 effective on date the Convention on Psychotropic Substances enters into force in the United States [July 15, 1980], see section 112 of Pub. L. 95&ndash;633, set out as an Effective Date note under section 801a of this title.</p>
<!-- field-end:effectivedate-amendment-note -->
<!-- field-start:miscellaneous-note -->
<h4 class="note-head">Provisional Registration</h4>
<p class="note-body">For provisional registration of persons engaged in manufacturing, distributing, or dispensing of controlled substances on the day before the effective date of section 822 of this title who are registered on such date under section 360 of this title or section 4722 of Title 26, Internal Revenue Code, see section 703 of Pub. L. 91&ndash;513, set out as a note under section 822 of this title.</p>
<!-- field-end:miscellaneous-note -->
<!-- field-end:notes -->
<!-- field-start:secref -->
<h4 class="note-head">Section Referred to in Other Sections</h4>
<!-- field-end:secref -->
<!-- field-start:sectionreferredto -->
<p class="note-body">This section is referred to in sections 824, 827, 828, 844, 880, 952, 958, 965 of this title.</p>
<!-- field-end:sectionreferredto -->


</body></html>